Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome
Sponsor: Bened Biomedical Co., Ltd.
Terminated
The covid-19 epidemic was calming down and not many people were suffering from the post covid 19 syndrome
Other terminated trials from Bened Biomedical Co., Ltd.
More terminations from Bened Biomedical Co., Ltd.
A NA clinical study on Post-COVID-19 Syndrome, this trial is terminated or withdrawn. The trial is conducted by Bened Biomedical Co., Ltd. and has accumulated 4 data snapshots since 2023. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Aug 2023 — Jul 2024 [monthly]
Recruiting NA
-
May 2023 — Aug 2023 [monthly]
Recruiting NA
First recorded
Jan 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bened Biomedical Co., Ltd.
- Mackay Memorial Hospital
For direct contact, visit the study record on ClinicalTrials.gov .